AbbVie (ABBV) Other financing activities (2012 - 2026)

AbbVie (ABBV) has 15 years of Other financing activities data on file, last reported at $2.0 million in Q1 2026.

• Other financing activities for Q1 2026 came in at $2.0 million, down 97.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (down 88.0% YoY), and the FY2025 annual result was $68.0 million, up 19.3% from the prior year.
• Other financing activities declined to $2.0 million in Q1 2026 per ABBV's latest filing, from $45.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $99.0 million in Q1 2024 and troughed at -$75.0 million in Q2 2024.
• A 5-year average of $12.8 million and a median of $10.0 million in 2022 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2022 and 2025: Other financing activities plunged 650.0% in 2022, then soared 4400.0% in 2025.
• A 5-year view of Other financing activities shows it stood at -$11.0 million in 2022, then surged by 536.36% to $48.0 million in 2023, then tumbled by 97.92% to $1.0 million in 2024, then soared by 4400.0% to $45.0 million in 2025, then plunged by 95.56% to $2.0 million in 2026.
• Business Quant data shows ABBV's Other financing activities at $2.0 million in Q1 2026, $45.0 million in Q4 2025, and -$9.0 million in Q3 2025.